You are here

BioNTech

FDA advisory panel recommends Pfizer Covid-19 vaccine be authorized for children

FDA advisory panel recommends Pfizer Covid-19 vaccine be authorized for children

Stat

Flag link:

Tracking the FDA's meeting on Pfizer's vaccine for kids

Tracking the FDA's meeting on Pfizer's vaccine for kids

BioPharma Dive

Flag link:

Pfizer, in a first, shows booster shot strengthens COVID-19 protection in large study

Pfizer, in a first, shows booster shot strengthens COVID-19 protection in large study

BioPharma Dive

clinical trials

Flag link:

Novartis signs new agreement with BioNTech for COVID-19 vaccine fill and finish

Novartis signs new agreement with BioNTech for COVID-19 vaccine fill and finish

Biopharma Reporter

drug manufacturing

Flag link:

Pfizer-BioNTech’s vaccine is highly effective against hospitalization for those 12 to 18, a study shows.

Pfizer-BioNTech’s vaccine is highly effective against hospitalization for those 12 to 18, a study shows.

NY Times, NY

Flag link:

Is mRNA the Future of Drug Development?

Is mRNA the Future of Drug Development?

BioSpace

drug development

Flag link:

Pfizer-BioNTech Lead Globally with COVID-19 Vaccine

Pfizer-BioNTech Lead Globally with COVID-19 Vaccine

BioSpace

Flag link:

Women's COVID-19 antibody levels top men's after 2nd Pfizer shot, study finds

Women's COVID-19 antibody levels top men's after 2nd Pfizer shot, study finds

Beckers Hospital Review

Flag link:

Pfizer, BioNTech ask FDA to authorize Covid-19 vaccine for kids 5-11

Pfizer, BioNTech ask FDA to authorize Covid-19 vaccine for kids 5-11

Politico

Flag link:

5 FDA approval decisions to watch in the fourth quarter

5 FDA approval decisions to watch in the fourth quarter

BioPharma Dive

Intra-Cellular Therapies

Moderna Therapeutics

Flag link:

How Big of an Opportunity Do Pfizer and BioNTech Have in Vaccinating Younger Kids?

How Big of an Opportunity Do Pfizer and BioNTech Have in Vaccinating Younger Kids?

Motley Fool

Flag link:

CDC panel clears way for Pfizer booster shots, but divided on broader use

CDC panel clears way for Pfizer booster shots, but divided on broader use

BioPharma Dive

Flag link:

Pfizer, Moderna, AZ and other COVID vaccine companies face urgent calls to ramp up access around the world

Pfizer, Moderna, AZ and other COVID vaccine companies face urgent calls to ramp up access around the world

Fierce Pharma

Amnesty International

Moderna Therapeutics

intellectual property

Flag link:

Pfizer Covid-19 vaccine generates robust antibody response in children, without serious safety issues, company says

Pfizer Covid-19 vaccine generates robust antibody response in children, without serious safety issues, company says

Stat

clinical trials

Flag link:

Why BioNTech Topped the Market on Tuesday

Why BioNTech Topped the Market on Tuesday

Motley Fool

Flag link:

Pfizer-BioNTech To Seek Approval For First Covid Vaccine For Young Children ‘In Next Few Weeks’

Pfizer-BioNTech To Seek Approval For First Covid Vaccine For Young Children ‘In Next Few Weeks’

Forbes

Flag link:

Why Moderna Boosters May Not Be Available as Soon as Pfizer-BioNTech Boosters

Why Moderna Boosters May Not Be Available as Soon as Pfizer-BioNTech Boosters

Motley Fool

Moderna Therapeutics

Flag link:

BioNTech reports promising data on mRNA cocktail in mouse models of colon cancer and melanoma

BioNTech reports promising data on mRNA cocktail in mouse models of colon cancer and melanoma

Fierce Biotech

Flag link:

EMA looks at booster data for Pfizer/BioNTech COVID-19 jab

EMA looks at booster data for Pfizer/BioNTech COVID-19 jab

Pharmaforum

Flag link:

Pfizer booster likely to be OK’d by Sept. 20, but Moderna’s may lag, Fauci says

Pfizer booster likely to be OK’d by Sept. 20, but Moderna’s may lag, Fauci says

Marketwatch

Moderna Therapeutics

Flag link:

Pages